465 related articles for article (PubMed ID: 26279432)
1. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
[TBL] [Abstract][Full Text] [Related]
2. β-elemene reverses chemoresistance of breast cancer via regulating MDR-related microRNA expression.
Zhang J; Zhang Hd; Chen L; Sun DW; Mao Cf; Chen W; Wu JZ; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2014; 34(6):2027-37. PubMed ID: 25562151
[TBL] [Abstract][Full Text] [Related]
3. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
4. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.
Chen WX; Liu XM; Lv MM; Chen L; Zhao JH; Zhong SL; Ji MH; Hu Q; Luo Z; Wu JZ; Tang JH
PLoS One; 2014; 9(4):e95240. PubMed ID: 24740415
[TBL] [Abstract][Full Text] [Related]
5. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.
Mao L; Li J; Chen WX; Cai YQ; Yu DD; Zhong SL; Zhao JH; Zhou JW; Tang JH
Tumour Biol; 2016 Apr; 37(4):5247-56. PubMed ID: 26555545
[TBL] [Abstract][Full Text] [Related]
6. d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission.
Chen WX; Xu LY; Qian Q; He X; Peng WT; Fan WQ; Zhu YL; Tang JH; Cheng L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061173
[TBL] [Abstract][Full Text] [Related]
7. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222.
Yu DD; Wu Y; Zhang XH; Lv MM; Chen WX; Chen X; Yang SJ; Shen H; Zhong SL; Tang JH; Zhao JH
Tumour Biol; 2016 Mar; 37(3):3227-35. PubMed ID: 26432333
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
9. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
[TBL] [Abstract][Full Text] [Related]
10. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
11. Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer.
Wang X; Xu C; Hua Y; Sun L; Cheng K; Jia Z; Han Y; Dong J; Cui Y; Yang Z
J Exp Clin Cancer Res; 2016 Dec; 35(1):186. PubMed ID: 27906043
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
13. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
[TBL] [Abstract][Full Text] [Related]
14. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
15. Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs.
Chen WX; Cai YQ; Lv MM; Chen L; Zhong SL; Ma TF; Zhao JH; Tang JH
Tumour Biol; 2014 Oct; 35(10):9649-59. PubMed ID: 24969560
[TBL] [Abstract][Full Text] [Related]
16. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
Xu HB; Li L; Fu J; Mao XP; Xu LZ
Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
[TBL] [Abstract][Full Text] [Related]
17. [Extraction and identification of exosomes from drug-resistant breast cancer cells and their potential role in cell-to-cell drug-resistance transfer].
Xu J; Li W; Zhong S; Li X; Chen Z; Hu Q; Tang J; Zhao J
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):165-70. PubMed ID: 24785274
[TBL] [Abstract][Full Text] [Related]
18. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein.
Lv MM; Zhu XY; Chen WX; Zhong SL; Hu Q; Ma TF; Zhang J; Chen L; Tang JH; Zhao JH
Tumour Biol; 2014 Nov; 35(11):10773-9. PubMed ID: 25077924
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
